# Anti-CMV Cellular Immunity Quantification Using an IGRA Test in Kidney Transplant récipients and Hemodialysis Patients, Comparison to Control Patients

> **NCT03916497** · — · COMPLETED · sponsor: **University Hospital, Grenoble** · enrollment: 60 (actual)

## Conditions studied

- Quantiferon-CMV
- Cytomegalovirus Infections
- Kidney Transplant Infection
- Hemodialysis

## Interventions

- **DIAGNOSTIC_TEST:** Quantiferon CMV

## Key facts

- **NCT ID:** NCT03916497
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-30
- **Primary completion:** 2019-07-30
- **Final completion:** 2019-07-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03916497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03916497, "Anti-CMV Cellular Immunity Quantification Using an IGRA Test in Kidney Transplant récipients and Hemodialysis Patients, Comparison to Control Patients". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03916497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*